Login to Your Account



Study Highlights New Potential Targets for Huntington's Disease

By Sharon Kingman
Staff Writer

Wednesday, February 22, 2012
LONDON – A type of drug that is already being evaluated as a treatment for Huntington's disease could have a valuable side effect that would also help reduce the progress of the condition, a new study suggested.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription